The present study demonstrated that FOXR2 had high expression in GECs, and silencing of FOXR2 decreased the expressions of ZO-1, occludin, and claudin-5 and increased the permeability of glioma-conditioned normal BBB. The gene discussed is CLDN5; the disease is central nervous system cancer.